Quarterly report [Sections 13 or 15(d)]

Operating Segments (Tables)

v3.26.3
Operating Segments (Tables)
 9 Months Ended
Sep. 30, 2026
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information

 

Segment Reporting for the Three Months Ended September 30, 2026

 

    Treatment     Services     Consolidated Total  
Revenue from external customers   $ 11,601     $ 6,347     $ 17,948  
Cost of Goods Sold:                        
Payroll and benefits expenses     5,728       2,720          
Material and supplies expenses     1,969       —          
Disposal expenses     1,104       —          
Transportation expenses     260       —          
Subcontract expenses     —       1,088          
Other cost of goods sold (1)     2,765       1,762          
Total cost of goods sold     11,826       5,570          
Gross (loss) profit     (225 )     777          
SG&A:                        
Payroll and benefits     916       399          
Other SG&A (2)     416       179          
Total SG&A     1,332       578          
R&D     165       3          
Gain on disposal of property and equipment     —       (5 )        
(Loss) income from operations   $ (1,722 )   $ 201       (1,521 )
Interest income                     240  
Interest expense                     (80 )
Interest expense-financing fees                     (16 )
Other income                     114  
Unallocated corporate expenses (3)                     (2,145 )
Loss from continuing operations before taxes                   $ (3,408 )


 

 

Segment Reporting for the Three Months Ended September 30, 2025

 

    Treatment     Services     Consolidated Total  
Revenue from external customers   $ 13,114     $ 4,340     $ 17,454  
Cost of Goods Sold:                        
Payroll and benefits expenses     4,809       2,358          
Material and supplies expenses     2,158        —          
Disposal expenses     1,075        —          
Transportation expenses     361        —          
Subcontract expenses      —       118          
Other cost of goods sold (1)     2,445       1,573          
Total cost of goods sold     10,848       4,049          
Gross profit     2,266       291          
SG&A:                        
Payroll and benefits     947       547          
Other SG&A (2)     386       199          
Total SG&A     1,333       746          
R&D     257       2          
Loss on disposal of property and equipment     4        —          
Income (loss) from operations   $ 672     $ (457 )     215  
Interest income                     266  
Interest expense                     (116 )
Interest expense-financing fees                     (22 )
Other expense                     (18 )
Unallocated corporate expenses (3)                     (2,087 )
Loss from continuing operations before taxes                   $ (1,762 )

 

Segment Reporting for the Nine Months Ended September 30, 2026

 

    Treatment     Services     Consolidated Total  
Revenue from external customers   $ 27,768     $ 14,191     $ 41,959  
Cost of Goods Sold:                        
Payroll and benefits expenses     15,950       7,142          
Material and supplies expenses     4,887       —          
Disposal expenses     3,470       —          
Transportation expenses     1,085       —          
Subcontract expenses     —       1,759          
Other cost of goods sold (1)     8,087       4,412          
Total cost of goods sold     33,479       13,313          
Gross profit     (5,711 )     878          
SG&A:                        
Payroll and benefits     2,685       1,561          
Other SG&A (2)     1,371       242          
Total SG&A     4,056       1,803          
R&D     584       7          
Gain on disposal of property and equipment     —       (5 )        
Loss from operations   $ (10,351 )   $ (927 )     (11,278 )
Interest income                     624  
Interest expense                     (213 )
Interest expense-financing fees                     (59 )
Other income                     258  
Unallocated corporate expenses (3)                     (6,378 )
Loss from continuing operations before taxes                   $ (17,046 )

 

Segment Reporting for the Nine Months Ended September 30, 2025

 

    Treatment     Services     Consolidated Total  
Revenue from external customers   $ 33,696     $ 12,263     $ 45,959  
Cost of Goods Sold:                        
Payroll and benefits expenses     13,988       6,245          
Material and supplies expenses     4,744       —

          
Disposal expenses     2,391        —          
Transportation expenses     1,222        —          
Subcontract expenses      —       1,184          
Other cost of goods sold (1)     7,269       4,155          
Total cost of goods sold     29,614       11,584          
Gross profit     4,082       679          
SG&A:                        
Payroll and benefits     2,763       1,732          
Other SG&A (2)     1,276       573          
Total SG&A     4,039       2,305          
R&D     780       29          
Loss (gain) on disposal of property and equipment     3       (5 )        
Loss from operations   $ (740 )   $ (1,650 )     (2,390 )
Interest income                     901  
Interest expense                     (351 )
Interest expense-financing fees                     (63 )
Other income                     171  
Unallocated corporate expenses (3)                     (6,112 )
Loss from continuing operations before taxes                   $ (7,844 )

 

(1)

Other cost of goods sold for each reportable segment includes:

 

Treatment - lab, regulatory, repair and maintenance, depreciation and amortization, travel, outside services and general expenses.

Services - material and supplies, disposal, transportation, lab, regulatory, repair and maintenance, depreciation and amortization, travel, outside services and general expenses.
   
(2)

Other SG&A for each reportable segment includes:

 

Treatment- depreciation and amortization, travel, outside services, repair and maintenance and general expenses.

Services- travel, outside services, repair and maintenance and general expenses.
   
(3) The following table reflects the unallocated corporate expenses. “Other” unallocated corporate expenses consists of repair and maintenance, depreciation and amortization, travel, public company, outside services, general and R&D expenses. (in thousands)

Schedule of Unallocated Corporate Expenses

                 
    Three Months Ended     Nine Months Ended  
    September 30,     September 30,  
    2026     2025     2026     2025  
Payroll and benefits   $ 998     $ 997     $ 2,919     $ 2,869  
Other     1,147       1,090       3,459       3,243  
Total   $ 2,145     $ 2,087     $ 6,378     $ 6,112  

Schedule of Depreciation and Amortization

The following table presents depreciation and amortization for the three and nine months ended September 30, (in thousand):

 

                 
    Three Months Ended     Nine Months Ended  
    September 30,     September 30,  
    2026     2025     2026     2025  
Treatment   $ 454     $ 387     $ 1,358     $ 1,158  
Services     29       28       77       109  
Total segment     483       415       1,435       1,267  
Corporate     12       11       34       32  
Total   $ 495     $ 426     $ 1,469     $ 1,299